Abacavir Sulfate (188062-50-2): A Deep Dive

Abacavir salt sulfate, identified by the CAS number 188062502 , is a crucial medication utilized in the therapy of HIV disease . Its mechanism of action involves inhibiting reverse transcriptase , a vital protein for viral replication . Patients receiving this substance must undergo genetic screening prior to commencement, due to a risk of hypersensitivity response linked to the HLA-B*57:01 allele. This complication can range from mild reaction to a severe, life-threatening syndrome . Careful assessment and patient informing are therefore essential for safe and beneficial utilization of abacavir salt .

Abarelix: Understanding Compound 183552-38-7

Abarelix, also known as compound 183552-38-7, is a synthetic decapeptide designed for the treatment of benign prostatic hyperplasia . This drug functions as a targeted gonadotropin-releasing hormone (GnRH) antagonist , effectively suppressing androgen production. Research into the molecule has focused on its ability to lessen associated conditions and potentially give an alternative to invasive interventions. The molecular profile of 183552-38-7 is sophisticated , showcasing a particular amino acid sequence resulting in its particular mechanism of action . Additional clinical studies are being conducted to completely evaluate its extended safety and effectiveness .

Abiraterone Acetate: Properties and Identification via CAS 154229-18-2

Abiraterone ester is an copyrightal blocker of CYP17A1, an protein crucial for male hormone biosynthesis. Its chemical formula is C26H30O3, and it’s commonly identified by its Chemical Abstracts Service (CAS) Registry Number 154229-18-2, providing unique identifier for accurate identification. The compound's properties include notable affinity for CYP17A1, resulting in lower androgen levels and exhibiting certain white to off-white solid appearance. Further analysis using analytical methods is often conducted to AMBROXOL HCL 23828-92-4 establish identity and consistency.

CAS Number Spotlight: Abacavir Sulfate Form – 188062-50-2 CAS

This piece highlights on a significant pharmaceutical ingredient : Abacavir Sulfate , identified by its specific Chemical Abstracts Service (CAS) designation: 188062-50-2. It is a vital component in the management of Human Immunodeficiency Virus infection, frequently used in combination other reverse transcriptase inhibitor medications . Familiarizing yourself with this chemical designation is helpful for professionals in the pharmaceutical industry .

Key points regarding Abacavir Sulfate Form:

  • Function : Acts as a nucleoside reverse transcriptase inhibitor .
  • Utility: Mainly used in AIDS treatment .
  • Verification: The CAS number 188062-50-2 offers accurate identification .

Decoding Abarelix: Structural Identity (183552-38-7)

Abarelix, identified by the unique identifier 183552-38-7, represents a fascinating example within the realm of peptide research. Its detailed makeup is crucial to its clinical function. Primarily, this compound is a synthetic hormone, designed to target and block gonadotropin-releasing releasing hormone. The structural formula reveals a sequence of residues carefully positioned to achieve a specific interaction with the GnRH site.

  • More investigation are conducted to fully determine its process of influence.
  • Understanding its production is vital for scaling up generation.
  • The exact series dictates its strength.

Abiraterone Compound (154229-18-2): Uses and Structural Profile

{Abiraterone Compound, with the CAS number 154229-18-2, is a drug primarily utilized in the management of metastatic male tumor, specifically those exhibiting mutations in the phosphatase tensin pathway. It functions as an blocker of copyrightal P450c17, an enzyme responsible for androgen biosynthesis . Chemically, it’s a laboratory-created compound with a complex design , intended to effectively lower androgen levels. Its medical usage has significantly advanced outcomes for patients with advanced prostate cancer .

Leave a Reply

Your email address will not be published. Required fields are marked *